Isaac Barchas sold $8.3M of Immunome (IMNM)

Executed Dec 22 2025, disclosed Dec 23 2025, 1 day later.

Value, as filed

$8.3M

383,200 sh across 2 lots

Executed

Dec 22 2025

the trade date, as filed

Disclosed

Dec 23 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Isaac Barchas Director profile →

Isaac Barchas (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Immunome, Inc. (IMNM). The largest single filing was $8.3M of IMNM (383,200 sh across 2 lots, as filed), executed Dec 22 2025.

The name

IMNM

Immunome, Inc. IMNM · Healthcare · 26 filings in 24 months ticker →

Healthcare · Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-dr…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Isaac Barchas in IMNM

IMNMSALE Immunome, Inc. $2.2M
83,464 sh across 3 lots
Exec Aug 10
Filed Aug 12 · 5:47 PM ET IMNMSALE Immunome, Inc. $940K
36,088 sh across 2 lots
Exec Aug 6
Filed Aug 10 · 4:10 PM ET IMNMSALE Immunome, Inc. $2.4M
100,000 sh across 2 lots
Exec Jul 6
Filed Jul 7 · 7:02 PM ET IMNMSALE Immunome, Inc. $4.4M
201,050 sh across 3 lots
Exec Jun 30
Filed Jul 2 · 8:31 PM ET